Emily L. Lowe, Ph.D. - Publications
Affiliations: | 2010 | University of California, Los Angeles, Los Angeles, CA |
Area:
Immunology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Burke BP, Levin BR, Zhang J, Sahakyan A, Boyer J, Carroll MV, Colón JC, Keech N, Rezek V, Bristol G, Eggers E, Cortado R, Boyd MP, Impey H, Shimizu S, ... Lowe EL, et al. Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector. Molecular Therapy. Nucleic Acids. 4: e236. PMID 25872029 DOI: 10.1038/Mtna.2015.10 | 0.342 | |||
2012 | Ringpis GE, Shimizu S, Arokium H, Camba-Colón J, Carroll MV, Cortado R, Xie Y, Kim PY, Sahakyan A, Lowe EL, Narukawa M, Kandarian FN, Burke BP, Symonds GP, An DS, et al. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice. Plos One. 7: e53492. PMID 23300932 DOI: 10.1371/Journal.Pone.0053492 | 0.368 | |||
2010 | Lowe EL, Crother TR, Rabizadeh S, Hu B, Wang H, Chen S, Shimada K, Wong MH, Michelsen KS, Arditi M. Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. Plos One. 5: e13027. PMID 20885960 DOI: 10.1371/Journal.Pone.0013027 | 0.319 | |||
Show low-probability matches. |